In 3xTg-AD mice, the combination of anti-Aβ/anti-NLRP3 antibodies inhibited inflammasome activation, resulting in lowered tau phosphorylation and IL-1β [136]. This evidence concerns the gene NLRP3 and Alzheimer disease.